The Diagnostic Value of Hepatic Arterial Velocity in Venoocclusive Disease After Pediatric Hematopoietic Stem Cell Transplantation

被引:7
|
作者
Kaya, Nusabe [1 ]
Erbey, Fatih [2 ,3 ]
Atay, Didem [2 ,3 ]
Akcay, Arzu [2 ,3 ]
Bozkurt, Ceyhun [4 ]
Ozturk, Gulyuz [2 ,3 ]
机构
[1] Istanbul Kemerburgaz Univ, Sch Med, Dept Radiol, Med Pk Hosp Bahcelievler, Istanbul, Turkey
[2] Acibadem Univ, Sch Med, Atakent Hosp, Dept Pediat Hematol Oncol, Istanbul, Turkey
[3] Acibadem Univ, Sch Med, Atakent Hosp, Bone Marrow Transplantat Unit, Istanbul, Turkey
[4] Med Pk Hosp Bahcelievler, Pediat Hematol Oncol & Bone Marrow Transplantat U, Istanbul, Turkey
关键词
hematopoietic stem cell transplantation; Doppler ultrasonography; venoocclusive disease; maximal systolic velocity of hepatic artery; hepatic arterial buffer response; BONE-MARROW-TRANSPLANTATION; DOPPLER ULTRASONOGRAPHIC EVALUATION; VENO-OCCLUSIVE DISEASE; DUPLEX SONOGRAPHY; VENOCCLUSIVE DISEASE; BLOOD-FLOW; COMPUTED-TOMOGRAPHY; PERFUSION INDEX; LIVER-DISEASE; PORTAL-VEIN;
D O I
10.1097/MPH.0000000000000799
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to determine usefulness of measurements of maximal systolic velocity of the hepatic artery with Doppler ultrasonography in the diagnosis of venoocclusive disease (VOD) after hematopoietic stem cell transplantation. We prospectively obtained 5 sonograms per patient: pretransplantation, day + 1, + 7, + 14, and + 28 on 36 nonconsecutive children who underwent hematopoietic stem cell transplantation. We examined the hepatic artery, the portal, hepatic and splenic veins, the thickness of the gallbladder wall, the presence of ascites, and the liver and spleen size. The diagnosis of VOD was based on clinical and laboratory data. Patients were divided into 2 groups: those with VOD (n=18) and those without VOD (n=18). The variance of 2 groups was analyzed. V-max of the hepatic artery had a strong correlation with clinical VOD diagnosis (P<0.001). There was no statistically significant difference in the other Doppler parameters. The results of our study showed that the measurement of V-max of the hepatic artery can provide important support in the diagnosis of VOD and can be useful in the follow-up of treatment response.
引用
收藏
页码:249 / 253
页数:5
相关论文
共 50 条
  • [1] CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation
    Erturk, Sukru Mehmet
    Mortele, Koenraad J.
    Binkert, Christoph A.
    Glickman, Jonathan N.
    Oliva, Maria-Raquel
    Ros, Pablo R.
    Silverman, Stuart G.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2006, 186 (06) : 1497 - 1501
  • [2] The Pathology of Pulmonary Disease After Pediatric Hematopoietic Stem Cell Transplantation
    Cortes-Santiago, Nahir
    Deutsch, Gail
    Patel, Kalyani R.
    Silva-Carmona, Manuel
    Henderson, Carolyn
    Sartain, Sarah E.
    Bhar, Saleh
    Pogoriler, Jennifer
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2024, 48 (10) : 1201 - 1214
  • [3] Echocardiography Monitoring of Pulmonary Hypertension after Pediatric Hematopoietic Stem Cell Transplantation: Pediatric Pulmonary Arterial Hypertension and Pulmonary Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation
    Kawashima, Nozomu
    Fukasawa, Yoshie
    Nishikawa, Eri
    Ohta-Ogo, Keiko
    Ishibashi-Ueda, Hatsue
    Hamada, Motoharu
    Ichikawa, Daisuke
    Narita, Atsushi
    Okuno, Yusuke
    Muramatsu, Hideki
    Nishio, Nobuhiro
    Kojima, Seiji
    Kato, Taichi
    Takahashi, Yoshiyuki
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (09): : 786.e1 - 786.e8
  • [4] Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation
    Cheuk, D. K. L.
    Wang, P.
    Lee, T. L.
    Chiang, A. K. S.
    Ha, S. Y.
    Lau, Y. L.
    Chan, G. C. F.
    BONE MARROW TRANSPLANTATION, 2007, 40 (10) : 935 - 944
  • [5] Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation
    Corbacioglu, Selim
    Kernan, Nancy
    Lehmann, Leslie
    Brochstein, Joel
    Revta, Carolyn
    Grupp, Stephan
    Martin, Paul
    Richardson, Paul G.
    EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (03) : 291 - 302
  • [6] Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation
    D K L Cheuk
    P Wang
    T L Lee
    A K S Chiang
    S Y Ha
    Y L Lau
    G C F Chan
    Bone Marrow Transplantation, 2007, 40 : 935 - 944
  • [7] The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan
    Lee, Chien-Chang
    Chang, Hsiu-Hao
    Lu, Meng-Yao
    Yang, Yung-Li
    Chou, Shu-Wei
    Lin, Dong-Tsamn
    Jou, Shiann-Tarng
    Yao, Ming
    Li, Chi-Cheng
    Yeh, Su-Peng
    Chen, Mei-Hui
    Gau, Jyh-Pyng
    Li, Sin-Syue
    Wang, Po-Nan
    Liu, Yi-Chang
    Wang, Tso-Fu
    Tan, Tran-Der
    Lee, Ming-Yang
    Yu, Ming-Sun
    Wang, Chuan-Cheng
    Lin, Shih-Chiang
    Chen, Yeu-Chin
    Su, Yung-Cheng
    Su, Ko-Ying
    Lin, Kai-Hsin
    ANNALS OF HEMATOLOGY, 2019, 98 (03) : 745 - 752
  • [8] Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation
    Schneider, Veronika
    Cabanillas Stanchi, Karin M.
    Althaus, Karina
    Schober, Sarah
    Michaelis, Sebastian
    Seitz, Christian
    Lang, Peter
    Handgretinger, Rupert
    Bakchoul, Tamam
    Hammer, Stefanie
    Doering, Michaela
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (11) : 8443 - 8453
  • [9] Gallbladder wall oedema and ascites are independent predictors of progression to hepatic veno-occlusive disease for children with hematopoietic stem cell transplantation
    Park, Ji Eun
    Choi, Young Hun
    Cheon, Jung-Eun
    Kim, Woo Sun
    Kim, In-One
    Ryu, Young Jin
    Kim, Yu Jin
    Hong, Che Ry
    Kang, Hyoung Jin
    EUROPEAN RADIOLOGY, 2018, 28 (06) : 2291 - 2298
  • [10] Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome
    Lee, S. H.
    Yoo, K. H.
    Sung, K. W.
    Koo, H. H.
    Kwon, Y. J.
    Kwon, M. M.
    Park, H. J.
    Park, B-K
    Kim, Y. Y.
    Park, J. A.
    Im, H. J.
    Seo, J. J.
    Kang, H. J.
    Shin, H. Y.
    Ahn, H. S.
    BONE MARROW TRANSPLANTATION, 2010, 45 (08) : 1287 - 1293